3D Global Biotech Inc. (6808.TWO) stock: key figures, P/E, revenue and dividend
Health Care · Taiwan · ISIN TW0006808009
3D Global Biotech Inc. financials
| Fiscal year | 2024 | 2025 |
|---|---|---|
| Revenue | 265.69 m TWD | 206.74 m TWD |
| Gross profit | 174.51 m TWD | 148.41 m TWD |
| Operating income | 88.70 m TWD | 44.22 m TWD |
| EBIT | 96.19 m TWD | 53.71 m TWD |
| Net income | 91.70 m TWD | 66.53 m TWD |
| Diluted EPS – continuing operations | 1.30 TWD | 0.86 TWD |
Full history since 2019, charts and your own formulas
This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.
About 3D Global Biotech Inc.
3D Global Biotech Inc. manufactures and sells medical devices for human body reconstruction. It offers artificial bone grafting; 3D bioForming; bio-dressing; 3D bioture EX; 3D printing equipment, such as 3D BioRealizer system; orthodontic aligner system under the SmileAlign name; and iMatrix, a sectional matrix kit. The company was founded in 2014 and is based in New Taipei City, Taiwan.
More stocks
- Link Solution Co., Ltd. (474650.KQ)
- Korea Pharmacy Co. Ltd. (032300.KQ)
- Seco/Warwick SA (SWG.WA)
- AMCON DISTRIBUTING CO (DIT)
- PYXUS INTERNATIONAL, INC. (PYYX)
- PLAYSTUDIOS, Inc. (MYPS)
- Sturgis Bancorp Inc (STBI)
- SDI Logística Rio - Fundo de Investimento Imobiliário - FII (TRBL11.SA)
- Airsculpt Technologies, Inc. (AIRS)
- Kamux Suomi Oy (KAMUX.HE)
- Homeland Nickel Inc. (SHL.V)
- Feei Cherng Develop Technology Co., Ltd. (3313.TWO)
Not investment advice. All data without warranty, price as of 13.11.2026. Details in the risk notice.